861673-69-0

Basic information

• Product Name: 2-(2-tert-butyl-phenoxy)-3-isothiocyanato-pyridine
• Synonyms: 2-(2-tert-butyl-phenoxy)-3-isothiocyanato-pyridine
• CAS NO: 861673-69-0
• Molecular Weight: 284.382
• Mol File: 861673-69-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-(2-tert-butyl-phenoxy)-3-isothiocyanato-pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-tert-butyl-phenoxy)-3-isothiocyanato-pyridine(861673-69-0)
• EPA Substance Registry System: 2-(2-tert-butyl-phenoxy)-3-isothiocyanato-pyridine(861673-69-0)

Safety Data

• Hazardous Substances Data: 861673-69-0(Hazardous Substances Data)

Upstream product

• 861673-67-8 2-(2-(tert-butyl)phenoxy)-3-nitropyridine 
• 88-18-6 2-tert-Butylphenol 
• 1480-87-1 2-fluoro-3-nitropyridine 
• 861673-68-9 2-(2-(tert-butyl)phenoxy)pyridin-3-amine 
• 102368-13-8 1,1'-Thiocarbonyldi-2(1H)-pyridone 
• 6160-65-2 1,1'-Thiocarbonyldiimidazole 

Downstream Products

• 861673-87-2 1-(2-(2-tert-butylphenoxy)pyridin-3-yl)-3-(2-methyl-4-(trifluoromethoxy)phenyl)thiourea 
• 861673-81-6 1-(2-(2-tert-butylphenoxy)pyridin-3-yl)-3-(4-(trifluoromethyl)phenyl)thiourea 
• 1440752-52-2 C₂₃H₂₄N₄O₂S 
• 1440752-81-7 C₂₅H₂₆N₂O₂S 
• 861673-80-5 1-(2-(2-tert-butylphenoxy)pyridin-3-yl)-3-(3-tert-butylphenyl)thiourea 
• 861673-70-3 1-(2-amino-4-methyl-phenyl)-3-[2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-thiourea 
• 861673-71-4 1-(2-amino-5-methyl-phenyl)-3-[2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-thiourea 
• 861673-77-0 1-(2-(2-tert-butylphenoxy)pyridin-3-yl)-3-p-tolylthiourea 

Relevant articles and documents

2-Aminothiazole based P2Y1 antagonists as novel antiplatelet agents

ADP receptors, P2Y1 and P2Y12 have been recognized as potential targets for antithrombotic drugs. A series of P2Y1 antagonists that contain 2-aminothiazoles as urea surrogates were discovered. Extensive SAR of the thiazole

AMINO-BENZAZOLES AS P2Y1 RECEPTOR INHIBITORS

The present invention provides novel amino-benzazoles and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating dis